Company Filing History:
6 out of 1,975 
1 out of 152 
1 out of 1,624 
Years Active: 2009-2016
Title: Kenneth D Wild, Jr: Innovator in Nerve Growth Factor Research
Introduction
Kenneth D Wild, Jr. is a notable inventor based in Simi Valley, CA (US). He has made significant contributions to the field of medical research, particularly in the area of nerve growth factor (NGF) and its implications in various disorders. With a total of 6 patents to his name, Wild's work has the potential to impact the treatment of chronic pain and other NGF-related conditions.
Latest Patents
Wild's latest patents include innovative methods for treating conditions caused by increased expression of nerve growth factor (NGF) or increased sensitivity to NGF. His invention provides antibodies that interact with or bind to human nerve growth factor (NGF) and neutralize its function. This invention also includes pharmaceutical compositions of these antibodies and methods for neutralizing NGF function, particularly for treating NGF-related disorders such as chronic pain. Additionally, he has developed methods for detecting the amount of NGF in a sample using anti-NGF antibodies. Another significant patent involves peptides and related molecules that modulate nerve growth factor activity, which can be used therapeutically against diseases linked to NGF.
Career Highlights
Throughout his career, Kenneth D Wild, Jr. has worked with prominent companies in the biotechnology sector, including Amgen Inc. and Medarex Inc. His experience in these organizations has contributed to his expertise in the field and has facilitated his innovative research.
Collaborations
Wild has collaborated with notable colleagues such as Haichun Huang and Heather Inoue. These partnerships have likely enhanced his research capabilities and broadened the impact of his inventions.
Conclusion
Kenneth D Wild, Jr. is a distinguished inventor whose work in nerve growth factor research has the potential to transform treatment options for various disorders. His innovative patents and collaborations reflect his commitment to advancing medical science.